Human Gene OAS3 (ENST00000228928.12_9) from GENCODE V47lift37
  Description: 2'-5'-oligoadenylate synthetase 3 (from RefSeq NM_006187.4)
Gencode Transcript: ENST00000228928.12_9
Gencode Gene: ENSG00000111331.14_16
Transcript (Including UTRs)
   Position: hg19 chr12:113,376,279-113,411,056 Size: 34,778 Total Exon Count: 16 Strand: +
Coding Region
   Position: hg19 chr12:113,376,336-113,407,778 Size: 31,443 Coding Exon Count: 16 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr12:113,376,279-113,411,056)mRNA (may differ from genome)Protein (1087 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGeneCardsHGNC
MalacardsMGIOMIMPubMedReactomeUniProtKB
WikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: OAS3_HUMAN
DESCRIPTION: RecName: Full=2'-5'-oligoadenylate synthase 3; Short=(2-5')oligo(A) synthase 3; Short=2-5A synthase 3; EC=2.7.7.-; AltName: Full=p100 OAS; Short=p100OAS;
FUNCTION: Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes preferentially dimers of 2'-5'- oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L. Displays antiviral activity against Chikungunya virus (CHIKV), Dengue virus, Sindbis virus (SINV) and Semliki forest virus (SFV).
CATALYTIC ACTIVITY: Binds double-stranded RNA and polymerizes ATP into PPP(A2'P5'A)N oligomers, which activate the latent RNase L that, when activated, cleaves single-stranded RNAs.
COFACTOR: Magnesium (Potential).
ENZYME REGULATION: Produced as a latent enzyme which is activated by dsRNA generated during the course of viral infection. The dsRNA activator must be at least 15 nucleotides long, and no modification of the 2'-hydroxyl group is tolerated. ssRNA or dsDNA do not act as activators.
SUBUNIT: Monomer.
INTERACTION: Q7L2E3:DHX30; NbExp=2; IntAct=EBI-6115729, EBI-1211456; P56537:EIF6; NbExp=2; IntAct=EBI-6115729, EBI-372243; Q8IY81:FTSJ3; NbExp=2; IntAct=EBI-6115729, EBI-744088; Q12894:IFRD2; NbExp=2; IntAct=EBI-6115729, EBI-6115935; Q7Z434:MAVS; NbExp=2; IntAct=EBI-6115729, EBI-995373;
SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
TISSUE SPECIFICITY: Present at high level in placenta trophoblast.
INDUCTION: By type I interferon (IFN) and viruses.
SIMILARITY: Belongs to the 2-5A synthase family.
SEQUENCE CAUTION: Sequence=AAD28543.1; Type=Frameshift; Positions=394, 398;

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: OAS3
Diseases sorted by gene-association score: chikungunya (27), tick-borne encephalitis (17), west nile encephalitis (11), microphthalmia with limb anomalies (8), retinitis pigmentosa 23 (6)

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 53.40 RPKM in Cells - EBV-transformed lymphocytes
Total median expression: 174.40 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -20.6057-0.361 Picture PostScript Text
3' UTR -1056.603278-0.322 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR006117 - 2-5-oligoadenylate_synth_CS
IPR006116 - 2-5-oligoadenylate_synth_N
IPR018952 - 2-5-oligoAdlate_synth_1_dom2/C
IPR026774 - 2-5A_synthase
IPR002934 - Nucleotidyltransferase

Pfam Domains:
PF01909 - Nucleotidyltransferase domain
PF10421 - 2'-5'-oligoadenylate synthetase 1, domain 2, C-terminus

SCOP Domains:
81631 - PAP/OAS1 substrate-binding domain
81301 - Nucleotidyltransferase

ModBase Predicted Comparative 3D Structure on Q9Y6K5
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0001730 2'-5'-oligoadenylate synthetase activity
GO:0003723 RNA binding
GO:0003725 double-stranded RNA binding
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0016740 transferase activity
GO:0016779 nucleotidyltransferase activity
GO:0046872 metal ion binding

Biological Process:
GO:0002376 immune system process
GO:0006139 nucleobase-containing compound metabolic process
GO:0006955 immune response
GO:0009615 response to virus
GO:0045071 negative regulation of viral genome replication
GO:0045087 innate immune response
GO:0051607 defense response to virus
GO:0060333 interferon-gamma-mediated signaling pathway
GO:0060337 type I interferon signaling pathway
GO:0060700 regulation of ribonuclease activity

Cellular Component:
GO:0005615 extracellular space
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0043231 intracellular membrane-bounded organelle


-  Descriptions from all associated GenBank mRNAs
  LP895852 - Sequence 716 from Patent EP3253886.
AB044545 - Homo sapiens P/OKcl.4 mRNA for 2'-5' oligoadenylate synthetase 3, complete cds.
AK000608 - Homo sapiens cDNA FLJ20601 fis, clone KAT07215, highly similar to AF063613 Homo sapiens 2'-5'oligoadenylate synthetase 3.
HI119095 - Sequence 5 from Patent EP1929042.
BC113746 - Homo sapiens 2'-5'-oligoadenylate synthetase 3, 100kDa, mRNA (cDNA clone MGC:133260 IMAGE:40036464), complete cds.
BC012015 - Homo sapiens 2'-5'-oligoadenylate synthetase 3, 100kDa, mRNA (cDNA clone IMAGE:4526805), with apparent retained intron.
AK292949 - Homo sapiens cDNA FLJ78682 complete cds, highly similar to Homo sapiens 2'-5'-oligoadenylate synthetase 3, 100kDa (OAS3), mRNA.
AF063613 - Homo sapiens 2'-5'oligoadenylate synthetase 3 (OAS3) mRNA, complete cds.
JD459094 - Sequence 440118 from Patent EP1572962.
JD084611 - Sequence 65635 from Patent EP1572962.
JD319208 - Sequence 300232 from Patent EP1572962.
JD333860 - Sequence 314884 from Patent EP1572962.
JD314861 - Sequence 295885 from Patent EP1572962.
JD280287 - Sequence 261311 from Patent EP1572962.
JD239295 - Sequence 220319 from Patent EP1572962.
JD176770 - Sequence 157794 from Patent EP1572962.
JD283880 - Sequence 264904 from Patent EP1572962.
JD281888 - Sequence 262912 from Patent EP1572962.
JD549318 - Sequence 530342 from Patent EP1572962.
JD171704 - Sequence 152728 from Patent EP1572962.
JD272685 - Sequence 253709 from Patent EP1572962.
JD150399 - Sequence 131423 from Patent EP1572962.
JD151082 - Sequence 132106 from Patent EP1572962.
JD086187 - Sequence 67211 from Patent EP1572962.
JD520031 - Sequence 501055 from Patent EP1572962.
JD163966 - Sequence 144990 from Patent EP1572962.
JD415706 - Sequence 396730 from Patent EP1572962.
JD120164 - Sequence 101188 from Patent EP1572962.
JD500250 - Sequence 481274 from Patent EP1572962.
JD224756 - Sequence 205780 from Patent EP1572962.
JD543984 - Sequence 525008 from Patent EP1572962.
JD432838 - Sequence 413862 from Patent EP1572962.
JD292076 - Sequence 273100 from Patent EP1572962.
JD375925 - Sequence 356949 from Patent EP1572962.
JD056479 - Sequence 37503 from Patent EP1572962.
JD144187 - Sequence 125211 from Patent EP1572962.
JD525883 - Sequence 506907 from Patent EP1572962.
JD064861 - Sequence 45885 from Patent EP1572962.
JD241199 - Sequence 222223 from Patent EP1572962.
JD423389 - Sequence 404413 from Patent EP1572962.
JD054908 - Sequence 35932 from Patent EP1572962.
JD392708 - Sequence 373732 from Patent EP1572962.
JD329738 - Sequence 310762 from Patent EP1572962.
JD285357 - Sequence 266381 from Patent EP1572962.
JD199955 - Sequence 180979 from Patent EP1572962.
JD253032 - Sequence 234056 from Patent EP1572962.
JD487989 - Sequence 469013 from Patent EP1572962.
JD528999 - Sequence 510023 from Patent EP1572962.
JD040452 - Sequence 21476 from Patent EP1572962.
JD427929 - Sequence 408953 from Patent EP1572962.
JD436340 - Sequence 417364 from Patent EP1572962.
JD295836 - Sequence 276860 from Patent EP1572962.
JD040736 - Sequence 21760 from Patent EP1572962.
JD254358 - Sequence 235382 from Patent EP1572962.
JD506911 - Sequence 487935 from Patent EP1572962.
JD091750 - Sequence 72774 from Patent EP1572962.
JD132409 - Sequence 113433 from Patent EP1572962.
JD226444 - Sequence 207468 from Patent EP1572962.
JD147481 - Sequence 128505 from Patent EP1572962.
JD322347 - Sequence 303371 from Patent EP1572962.
JD184065 - Sequence 165089 from Patent EP1572962.
JD092695 - Sequence 73719 from Patent EP1572962.
JD463569 - Sequence 444593 from Patent EP1572962.
JD515363 - Sequence 496387 from Patent EP1572962.
JD436123 - Sequence 417147 from Patent EP1572962.
JD314682 - Sequence 295706 from Patent EP1572962.
JD221860 - Sequence 202884 from Patent EP1572962.
JD546821 - Sequence 527845 from Patent EP1572962.
JD429058 - Sequence 410082 from Patent EP1572962.
JD429764 - Sequence 410788 from Patent EP1572962.
JD303608 - Sequence 284632 from Patent EP1572962.
JD363348 - Sequence 344372 from Patent EP1572962.
JD310633 - Sequence 291657 from Patent EP1572962.
JD187010 - Sequence 168034 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q9Y6K5 (Reactome details) participates in the following event(s):

R-HSA-909733 Interferon alpha/beta signaling
R-HSA-877300 Interferon gamma signaling
R-HSA-913531 Interferon Signaling
R-HSA-1280215 Cytokine Signaling in Immune system
R-HSA-168256 Immune System

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000228928.1, ENST00000228928.10, ENST00000228928.11, ENST00000228928.2, ENST00000228928.3, ENST00000228928.4, ENST00000228928.5, ENST00000228928.6, ENST00000228928.7, ENST00000228928.8, ENST00000228928.9, NM_006187, OAS3_HUMAN, P/OKcl.4, Q2HJ14, Q9H3P5, Q9Y6K5, uc317dpf.1, uc317dpf.2
UCSC ID: ENST00000228928.12_9
RefSeq Accession: NM_006187.4
Protein: Q9Y6K5 (aka OAS3_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.